Sign In
Buy LNTH
$101.11
-0.0800 (-0.0791%)
At Close: Aug 04, 2026
Why Lantheus Holdings Stock Is Skyrocketing Today
11:57am, Wednesday, 10'th Jul 2024
Medicare will likely soon change how it pays for diagnostic radiopharmaceuticals. Lantheus should be a big winner from this reimbursement change.
Lantheus Stock Gets A Radioactive Surge On Medicare Proposal
10:19am, Wednesday, 10'th Jul 2024
Lantheus stock rocketed to a 13-month high Wednesday after a Medicare proposal suggested hiking the reimbursement rate for some diagnostics.
Lantheus Appoints Jamie Spaeth as Chief People Officer
08:30am, Monday, 08'th Jul 2024
BEDFORD, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fi
Deal Further Strengthens Lantheus' Prostate Cancer Portfolio and Expands Pipeline to Include Breast Cancer Deal Further Strengthens Lantheus' Prostate Cancer Portfolio and Expands Pipeline to Include
Why Lantheus Holdings (LNTH) is a Top Momentum Stock for the Long-Term
10:55am, Monday, 24'th Jun 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
New Strong Buy Stocks for June 21st
08:30am, Friday, 21'st Jun 2024
ASYS, LAUR, ESLT, LNTH and LMAT have been added to the Zacks Rank #1 (Strong Buy) List on June 21, 2024.
Best Value Stocks to Buy for June 21st
06:10am, Friday, 21'st Jun 2024
LAUR, ESLT and LNTH made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 21, 2024.
Radiopharm Receives Strategic Investment for up to A$18 million
08:41pm, Thursday, 20'th Jun 2024
SYDNEY, June 20, 2024 (GLOBE NEWSWIRE) -- Radiopharm Theranostics Limited (ASX:RAD) (Radiopharm or the Company), a developer of diagnostic and therapeutic radiopharmaceutical products, has entered int
4 Medical Product Stocks to Buy From a Recovering Industry
08:30am, Wednesday, 19'th Jun 2024
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, RMD, LNTH and HAE are well-poised to
Lantheus (LNTH) Gains 33.3% YTD: What's Driving the Stock?
12:51pm, Tuesday, 18'th Jun 2024
Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
Don't Overlook These Highly Ranked Medical Stocks as Markets Rise
05:01pm, Wednesday, 12'th Jun 2024
With earnings estimate revisions on the rise for these top medical stocks, they certainly shouldn't be overlooked given their blazing historical performances.
New Strong Buy Stocks for June 12th
05:55am, Wednesday, 12'th Jun 2024
RDNT, ESLT, CLS, LNTH and ASBFY have been added to the Zacks Rank #1 (Strong Buy) List on June 12, 2024.
Lantheus Holdings (LNTH) Stock Drops Despite Market Gains: Important Facts to Note
07:20pm, Monday, 10'th Jun 2024
In the most recent trading session, Lantheus Holdings (LNTH) closed at $79.28, indicating a -0.78% shift from the previous trading day.
Buy These 3 Beaten-Down MedTech Stocks for a Turnaround Soon
10:36am, Friday, 07'th Jun 2024
Investing in beaten-down stocks like OPCH, LNTH and HOLX can be profitable for investors in the long term.
Lantheus' AI-Enabled aPROMISE Now Available on Siemens Healthineers' syngo.via platform
08:30am, Monday, 03'rd Jun 2024
The integrated aPROMISE solution to be demonstrated on Siemens Healthineers' syngo.via platform at the SNMMI annual meeting The integrated aPROMISE solution to be demonstrated on Siemens Healthineers'
